Acquired factor V inhibitor after antibiotic treatment in a patient with pneumonia: a case report

Ann Hematol. 2019 Aug;98(8):1989-1990. doi: 10.1007/s00277-019-03638-6. Epub 2019 Feb 12.

Authors

Masaya Taniwaki¹, Shinya Katsutani², Masahiro Yamasaki³, Kazuma Kawamoto³, Kunihiko Funaishi³, Yu Matsumoto³, Naoko Matsumoto³, Nobuyuki Ohashi^{3

4}, Noboru Hattori⁵

Affiliations

¹ Department of Respiratory Disease, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, 1-9-6 Senda-machi, Naka-ku, Hiroshima, 730-8619, Japan. graymzo@yahoo.co.jp.
² Department of Hematology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Naka-ku, Hiroshima, Japan.
³ Department of Respiratory Disease, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, 1-9-6 Senda-machi, Naka-ku, Hiroshima, 730-8619, Japan.
⁴ Ohashi Clinic, Naka-ku, Hiroshima, Japan.
⁵ Department of Molecular and Internal Medicine, Institute of Biomedical & Health Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan.

PMID: 30747247
DOI: 10.1007/s00277-019-03638-6

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Anti-Bacterial Agents / administration & dosage
Anti-Bacterial Agents / adverse effects*
Antibody Specificity
Antifungal Agents / administration & dosage
Antifungal Agents / adverse effects*
Autoantibodies / immunology*
Autoimmune Diseases / chemically induced*
Ceftriaxone / adverse effects
Cephalosporins / adverse effects
Ciprofloxacin / adverse effects
Drug Substitution
Drug Therapy, Combination
Factor V / immunology*
Factor V Deficiency / chemically induced*
Fluoroquinolones / adverse effects
Humans
Levofloxacin / adverse effects
Male
Meropenem / adverse effects
Micafungin / adverse effects
Partial Thromboplastin Time
Pneumonia / drug therapy*
Prothrombin Time

Substances

Anti-Bacterial Agents
Antifungal Agents
Autoantibodies
Cephalosporins
Fluoroquinolones
Ciprofloxacin
cefcapene pivoxil hydrochloride
Levofloxacin
Ceftriaxone
Factor V
Meropenem
Micafungin
garenoxacin